Investment

DDW Multimedia Editor Megan Thomas takes a broad look at the drug discovery and development landscape in Japan and highlights how it is bolstered by government policies, investment, collaboration, start-up ecosystems and academic research.   Japan continues to be one of the largest pharmaceutical markets in the world, despite what the International Trade Administration described as […]

Aqemia has raised €30 million in a Series A funding round to further support its mission to massively scale drug discovery through a first-in-class technological platform combining quantum-inspired physics and machine learning.  The financing was led by Eurazeo and Bpifrance through its Large Venture fund, with the participation of Elaia – its historic investor.   Aqemia’s […]

Danish microbiome research company Clinical Microbiomics has received a €10 million investment from ‘Health for Life Capital II’, managed by Seventure Partners. Microbiome venture capitalists Seventure Partners have backed growth companies in the microbiome field with funding through ‘Health for Life I’ and ‘Health for Life II’ since 2013. Microbiome science is considered to be […]

US biotechnology start-up LivFul has secured a $1.5m investment to expand its work saving lives from malaria and other insect-borne diseases, and to support the company’s growth plans.    The company’s major markets are now opening up following the pandemic, with interest in Livful’s Enhanced Insect Repellent ramping up. Livful is currently focussing its business development […]

Pleco Therapeutics BV has raised €17.3 million in its Series A financing round, which will be used to complete the development of its Plecoid Product, PTX-061, to improve the effectiveness of chemotherapy in patients with acute myeloid leukaemia (AML). The investments include €3.6 million committed by Oost NL and a select number of private investors, […]

Artificial intelligence (AI) company Atomwise has signed an exclusive research collaboration with Sanofi to use its AtomNet platform for computational discovery and research of up to five drug targets.  The agreement will see Atomwise receive $20 million from Sanofi to identify, synthesise, and advance lead compounds for up to five targets, which will be exclusive to […]

Clinical-stage drug discovery company Ryvu Therapeutics has received €22 million from the European Investment Bank (EIB) to help it advance its portfolio of cancer treatments.   The funding, which is being provided under the EIB’s venture debt instrument, will help Ryvu finance its development pipeline of new cancer treatments from discovery through to clinical trials. Ryvu’s […]

Life sciences property provider Bruntwood SciTech has invested £20 million into redeveloped laboratories at the UK’s North West research campus, Alderley Park.   The £20 million investment has gone towards the redevelopment of existing lab spaces to create high-specification biology and chemistry containment level two (CL2) laboratory suites. The labs have been designed to include spaces […]

The International Finance Corporation (IFC) is investing $30 million in the pharmaceutical company Laboratorios Siegfried to help provide lower-income populations across the Latin America and the Caribbean (LAC) regions with better access to high-quality and affordable healthcare products.  The investment falls under IFC’s Global Health Platform (GHP) and will support Siegfried’s expansion plans to boost […]

A UK centre for synthetic biology has received £5.5 million in funding so it can support start-ups and SMEs in the sector.  The UK’s National Centre for the Industrial Translation of Synthetic Biology, SynbiCITE, will use the funding to support businesses within the sector and to help strengthen the emerging UK bioeconomy. The centre was […]